These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10450046)

  • 1. High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis.
    Ohsawa I; Ohi H; Endo M; Fujita T; Seki M; Watanabe S
    Nephron; 1999; 82(4):366-7. PubMed ID: 10450046
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating complement levels and C3 glomerulopathy.
    Fervenza FC; Sethi S
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1829-31. PubMed ID: 25341723
    [No Abstract]   [Full Text] [Related]  

  • 3. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocomplementaemia in a newborn caused by transplacental passage of maternal autoantibody with C3 nephritic factor (C3 NeF) activity.
    Weiss L; Rougier N; Blouin J; Kazatchkine MD; Lhotta K; König P
    Nephrol Dial Transplant; 1995 Dec; 10(12):2374. PubMed ID: 8808251
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
    Hulton SA; Risdon RA; Dillon MJ
    Pediatr Nephrol; 1992 May; 6(3):239-43. PubMed ID: 1616831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
    Ohi H; Tanuma Y
    Nephron; 1992; 62(1):116. PubMed ID: 1436279
    [No Abstract]   [Full Text] [Related]  

  • 8. Low prevalence of antibodies to hepatitis C virus among adult patients with idiopathic membranoproliferative type I glomerulonephritis in France.
    Rostoker G; Deforges L; Ben Maadi A; Remy P; Lang P; Duval JR; Weil B
    Nephron; 1995; 69(1):97. PubMed ID: 7534382
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.
    West CD; Bissler JJ
    Pediatr Nephrol; 2008 Oct; 23(10):1867-76. PubMed ID: 18594868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-binding lectin contributes to glomerulonephritis induced by hepatitis C virus infection.
    Endo M; Ohsawa I; Ohi H; Fujita T; Matsushita M; Fujita T
    Nephron; 2001 Apr; 87(4):374-5. PubMed ID: 11287785
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration of C3 nephritic factor in a patient with membrano-proliferative glomerulonephritis type II.
    Seino J; Narita M; Noshiro H; Sato K; Sato H; Saito T; Abe K
    Nephron; 1995; 69(1):114-5. PubMed ID: 7891786
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nephritic factor in hypocomplementemia.
    Ohi H; Tanuma Y; Sato M; Yasugi T
    Nephron; 1993; 63(3):370. PubMed ID: 8446286
    [No Abstract]   [Full Text] [Related]  

  • 14. C3 nephritic factor and SLE: report of four cases and review of the literature.
    Walport MJ; Davies KA; Botto M; Naughton MA; Isenberg DA; Biasi D; Powell RJ; Cheung NT; Struthers GR
    QJM; 1994 Oct; 87(10):609-15. PubMed ID: 7987656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
    Häffner K; Michelfelder S; Pohl M
    Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A; Montagnino G; Scalia P; Tarantino A
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract]   [Full Text] [Related]  

  • 18. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is membranoproliferative glomerulonephritis an autoimmune disease?
    Ohi H; Tanuma Y; Hatano M
    Nephron; 1990; 54(2):192. PubMed ID: 2314532
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K; Ward D; Ruddy S
    Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.